𝔖 Bobbio Scriptorium
✦   LIBER   ✦

DNA microarrays in the clinic: infectious diseases

✍ Scribed by Vladimir Mikhailovich; Dmitry Gryadunov; Alexander Kolchinsky; Alexander A. Makarov; Alexander Zasedatelev


Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
319 KB
Volume
30
Category
Article
ISSN
0265-9247

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

We argue that the most‐promising area of clinical application of microarrays in the foreseeable future is the diagnostics and monitoring of infectious diseases. Microarrays for the detection and characterization of human pathogens have already found their way into clinical practice in some countries. After discussing the persistent, yet often underestimated, importance of infectious diseases for public health, we consider the technologies that are best suited for the detection and clinical investigation of pathogens. Clinical application of microarray technologies for the detection of mycobacteria, Bacillus anthracis, HIV, hepatitis and influenza viruses, and other major pathogens, as well as the analysis of their drug‐resistance patterns, illustrate our main thesis. BioEssays 30:673–682, 2008. Β© 2008 Wiley Periodicals, Inc.


πŸ“œ SIMILAR VOLUMES


DNA microarrays in the clinic: how soon,
✍ Bertrand R. Jordan πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 105 KB

## Abstract Although DNA microarrays are now widely used in research settings, they have been slow to penetrate clinical practice in spite of their apparent advantages. This is due to the very different requirements for a clinical test in contrast to a research tool, and to a strict necessity for d

Model-guided microarray implicates the r
✍ Scott A. Small; Kelly Kent; Aimee Pierce; Conrad Leung; Min Suk Kang; Hirokazu O πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 453 KB

## Abstract Although, in principle, gene expression profiling is well suited to isolate pathogenic molecules associated with Alzheimer's disease (AD), techniques such as microarray present unique analytic challenges when applied to disorders of the brain. Here, we addressed these challenges by firs